Puig-Davi, A, Franch-Marti, C, Ruiz-Barrio, I, Sampedro, F, Perez-Perez, J, Matias-Guiu, JA, Cuetos, F, Olmedo-Saura, G, Perez-Carasol, L, Horta-Barba, A, Aracil-Bolanos, I, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease. Annals of Clinical and Translational Neurology. 2025; 12(6)DOI:10.1002/acn3.70022. PMID:40244831. IF:3.900(Q1/3D).

Rodriguez-Antiguedad, J, Rajalingam, R, Krüger, C, Teixeira-dos-Santos, D, Sun, CSE, Fernandez-Toledo, E, Duarte, A, Saffie-Awad, P, Barrett, MJ, Flanigan, JL, Emamikhah, M, Patel, N, San Luciano, M, Cooper, C, Bahr, N, Oguh, O, Buhrmann, A, Vater, M, Fuchshofen, R, Vulinovic, F, Parreidt, MI, Weissbach, A, Lohmann, K, Klein, C, Marras, C, Camargos, S. Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes GLB1, SLC6A3, SLC30A10, SLC39A14, and PLA2G6: MDSGene Systematic Review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(9)DOI:10.3390/ijms26094074. PMID:40362326. IF:4.900(Q1/3D).

Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Rusiñol, AB, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martínez, SM, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Rodríguez-Molinero, A. Comparison of clinical measures of motor function with a Holter monitor in Parkinson's disease. Clinical Parkinsonism & Related Disorders. 2025; 12DOI:10.1016/j.prdoa.2025.100325. PMID:40329979. IF:(Q/D).

Martinez-Horta S., Perez-Perez J., Kulisevsky J.. Koro-like syndrome in Huntington's disease. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(1)DOI:10.1016/j.rpsm.2023.01.006. PMID:37852879. IF:2.800(Q/D).

Moreu-Valls, A, Puig-Davi, A, Martinez-Horta, S, Kulisevsky, G, Sampedro, F, Perez-Perez, J, Horta-Barba, A, Olmedo-Saura, G, Pagonabarraga, J, Kulisevsky, J. A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington's disease. JOURNAL OF NEUROLOGY. 2025; 272(3)DOI:10.1007/s00415-025-12927-2. PMID:39934473. IF:4.600(Q1/2D).

Pérez-Pérez, J, García-López, S, Valle, TF, Painous, C, Querol-Pascual, MR, Ruiz, PJG, Diago, EB, Delgado, EC, Pastor, BV, Villaplana, MCP, Santana, IM, Estrada, MB, Garride, MC, Mir, P, Alvarez, C, Maurino, J, de Prado, A, López-Sendón, JL. Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective (Nov, 10.1007/s40120-024-00655-0, 2024). Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00683-w. PMID:39570476. IF:4.800(Q1/2D).

Pérez-Pérez, J, García-López, S, Valle, TF, Painous, C, Querol-Pascual, MR, Ruiz, PJG, Diago, EB, Delgado, EC, Pastor, BV, Villaplana, MCP, Santana, IM, Estrada, MB, Garride, MC, Ribera, PM, Alvarez, C, Maurino, J, de Prado, A, López-Sendón, JL. Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00655-0. PMID:39370480. IF:4.800(Q1/2D).

Cattaneo, C, Pagonabarraga, J. Sex Differences in Parkinson's Disease: A Narrative Review. Neurology and Therapy. 2025; 14(1)DOI:10.1007/s40120-024-00687-6. PMID:39630386. IF:4.800(Q1/2D).

Rodríguez-Antigüedad, J, Olmedo-Saura, G, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Approaches for treating neuropsychiatric symptoms in Parkinson's disease: a narrative review. Therapeutic Advances in Neurological Disorders. 2025; 18DOI:10.1177/17562864251336903. PMID:40433403. IF:4.100(Q1/2D).

Berzosa-Gonzalez, I, Martinez-Horta, S, Pérez-Pérez, J, Kulisevsky, J, Pagonabarraga, J. Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities. Brain Sciences. 2024; 14(12)DOI:10.3390/brainsci14121231. PMID:39766430. IF:2.800(Q3/6D).

Gonzalez-Herrero, B, Happé, F, Nicholson, TR, Morgante, F, Pagonabarraga, J, Deeley, Q, Edwards, MJ. Functional Neurological Disorder and Autism Spectrum Disorder: A Complex and Potentially Significant Relationship. Brain and Behavior. 2024; 14(12)DOI:10.1002/brb3.70168. PMID:39705515. IF:2.700(Q2/3D).

Salvat-Rovira, N, Vazquez-Oliver, A, Rivas-Asensio, E, Herrero-Lorenzo, M, Gámez-Valero, A, Pérez-Pérez, J, Izquierdo, C, Campolongo, A, Marti, E, Kulisevsky, J, Pérez-González, R. Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(24)DOI:10.3390/ijms252413705. PMID:39769471. IF:4.900(Q1/3D).

de la Riva, P, Marta-Enguita, J, Rodríguez-Antigueedad, J, Bergareche, A, de Munain, AL. Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanalization Therapies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(21)DOI:10.3390/ijms252111631. PMID:39519182. IF:4.900(Q1/3D).

Herrero-Lorenzo, M, Pérez-Pérez, J, Escaramís, G, Martínez-Horta, S, Pérez-González, R, Rivas-Asensio, E, Kulisevsky, J, Gámez-Valero, A, Martí, E. Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease. Journal of Extracellular Vesicles. 2024; 13(10)DOI:10.1002/jev2.12522. PMID:39377487. IF:14.500(Q1/1D).

Ruiz-Barrio, I, Vázquez-Oliver, A, Puig-Davi, A, Rivas-Asensio, E, Perez-Perez, J, Fernandez-Vizuete, C, Horta-Barba, A, Olmedo-Saura, G, Salvat-Rovira, N, Sampedro, F, Vacchi, E, Melli, G, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Skin Tau Quantification as a Novel Biomarker in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(11)DOI:10.1002/mds.29989. PMID:39192729. IF:7.600(Q1/1D).

Busteed, L, García-Sánchez, C, Pascual-Sedano, B, Grunden, N, Gironell, A, Kulisevsky, J, Pagonabarraga, J. Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 2024; DOI:10.1093/arclin/acae062. PMID:39127889. IF:2.100(Q2/5D).

Puig-Davi, A, Martinez-Horta, S, Pérez-Carasol, L, Horta-Barba, A, Ruiz-Barrio, I, Aracil-Bolaños, I, Pérez-González, R, Rivas-Asensio, E, Sampedro, F, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers. ANNALS OF NEUROLOGY. 2024; 96(5)DOI:10.1002/ana.27035. PMID:39099459. IF:7.700(Q1/1D).

Santos-Garcia, D, de Deus, T, Cores, C, Painceiras, MJF, Alvarado, MCI, Samaniego, LB, Maside, AL, Jesus, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Lopez, IC, Manzanares, LL, Gonzalez-Aramburu, I, Avila, A, Gomez-Mayordomo, V, Nogueira, V, Garcia-Soto, JD, Borrue-Fernandez, C, Solano, B, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Parees, I, Alonso, PS, Losada, MGA, Lopez-Ariztegui, N, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordas, C, Menendez-Gonzalez, M, Mcafee, D, Martinez-Martin, P, Mir, P. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study. Movement Disorders Clinical Practice. 2024; 11(7)DOI:10.1002/mdc3.14056. PMID:38747234. IF:2.700(Q2/5D).

Gironell, A, Marín-Lahoz, J, Póveda, S. Essential Tremor: Update of Therapeutic Strategies. MEDICINA CLINICA. 2024; 162(12)DOI:10.1016/j.medcli.2023.12.013. PMID:38553256. IF:2.100(Q2/3D).

Dellarole, IL, Vacchi, E, Ruiz-Barrio, I, Pinton, S, Raimondi, A, Rossi, S, Morandi, S, Bianco, G, Bacinoglu, MB, Lombardo, A, Celauro, L, Staedler, C, Galati, S, Pagonabarraga, J, Kulisevsky, J, Legname, G, Gobbi, C, Kaelin-Lang, A, Moda, F, Melli, G. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies. npj Parkinsons Disease. 2024; 10(1)DOI:10.1038/s41531-024-00728-9. PMID:38879633. IF:8.200(Q1/1D).